The information contained in this document, be it guidelines, recommendations, diagnostic algorithms or treatment regimens, are offered in this document in the public interest. To the best of the knowledge of the guideline writing team, the information contained in these guidelines is correct. Imple...mentation of any aspect of these guidelines remains the responsibility of the implementing agency in so far as public health liability resides, or the responsibility of the individual clinician in the case of diagnosis or treatment.
more
Produced by Training and Research Support Centre for the Regional Network for Equity in Health in east and southern Africa (EQUINET), March 20, 2020.
This brief summarises and provides links to official, scientific and other resources to support an understanding of and individual to regional level... responses to the epidemic of ‘novel coronavirus’, also known as COVID-19.
more
Rapporto ISS COVID-19, n. 6/2020
Gruppo di Lavoro ISS Cause di morte COVID-19
Versione del 27 marzo 2020
Scientific Brief 9 July 2020
The purpose of this document is to provide guidance on how quarantine and isolation can be achieved if there is a suspected or confirmed case in an overcrowded setting. It will focus on informal settlements and collective shelters, but the guidance can be applied in non-refugee settings as well, suc...h as detention centres and crowded neighborhoods. This guidance aims to support a coordinated and efficient response. It supports detailed planning at the regional level and is meant to be adapted to the local context. Households residing outside of these shelter types will be expected to follow the self-isolation circular provided by the MoPH. It is preferable, whenever feasible, that people are supported to remain in their homes. This guidance note will be continuously adapted as needed from the National level.
more
Scientific brief
8 April 2020
Hasta el 1 de abril, se han confirmado oficialmente 144 casos de COVID-19 en 19 territorios (17 estados, Distrito Capital y Territorio Insular Francisco de Miranda -Los Roques-), incluyendo 43 personas recuperadas y 3 personas fallecidas.
• El 25 de marzo, el Secretario General de las Naciones Un...idas lanzó el Plan de Respuesta Humanitaria Global para responder al COVID-19 en 53 países, incluida Venezuela.
more
10 Janaury 2022 The following catalogue lists all the medical devices including personal protective equipment, medical equipment, medical consumables, single use devices and laboratory and test related devices.
Version: 2.0 Date: 19.3.2020
Segunda edición: 10 de abril 2020
Panorama de la situación en Venezuela y esfuerzos hasta la fecha
NB: desde la primera iteración de este Plan se ha observado el aumento de retornos de personas a Venezuela, principalmente entrando por vía terrestre desde Colombia, lo que requiere un esfuerzo e...special desde el punto de vista de control epidemiológico, estableciendo condiciones de alojamiento temporal adecuadas y de protección, lo que se refleja en esta segunda edición.
more
10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2 immunity from natural infection. More information about considera...tions on vaccine certificates or “passports” will be covered in an update of WHO interim guidance, as requested by the COVID-19 emergency committee.
more
временное руководство, 13 мая 2020 г.
Целью настоящего документа является предоставле- ние временных рекомендаций по биологической без- опасности в лабораторных усл...виях, которые следует соблюдать при исследовании клинических образцов пациентов, подпадающих под определение случаев ин- фицирования новым патогеном, выявленным в Ухане, Китай, то есть коронавирусным заболеванием 2019 г. COVID-19.
more
Interim Guidance 31 march 2020
WHO has established a shipment mechanism to expedite and cover the costs of the shipment of clinical samples from patients with suspected COVID-19 from the country of collection to one of the WHO reference laboratories providing confirmatory molecular testing for COVI...D-19. This document explains the process and documentation required for shipment of specimens.
more
Lignes directrices provisoires
17 janvier 2020
Le présent document a été rédigé en s’appuyant sur divers documents existants de l’OMS, y compris les lignes directrices de l’OMS relatives au dépistage en laboratoire du MERS-CoV (1-11). À mesure que de nouvelles informations seront r...ecueillies concernant l’étiologie, les manifestations cliniques et la transmission de la maladie dans le groupe de patients atteints de maladie respiratoire à Wuhan, l’OMS continuera de suivre l’évolution de la situation et révisera si nécessaire les présentes recommandations.
more
Este documento apresenta uma orientação provisória aos laboratórios e diferentes atores envolvidos na realização de exames laboratoriais para o vírus COVID-19. Ele baseia-se parcialmente na orientação provisória para os exames laboratoriais do coronavírus da Síndrome Respiratória do Ori...ente Médio (MERS).1-6 As informações sobre a infecção em humanos pelo vírus COVID-19 estão evoluindo e a OMS continua a monitorar os acontecimentos e revisar as recomendações conforme necessário. Este documento será revisado conforme novas informações forem disponibilizadas.
more
O objetivo deste documento é fornecer orientações provisórias de biossegurança laboratorial para testes com amostras clínicas de pacientes que atendam à definição de casos do novo patógeno identificado em Wuhan, China, ou seja, a doença do coronavírus 2019 (COVID-19). A OMS revisará ess...as recomendações conforme necessário.
more
As of 15 May 2020, more than 4 million confirmed cases of COVID-19, including more than 285,000 deaths have been reported to WHO. The risk of severe disease and death has been highest in older people and in persons with underlying noncommunicable diseases (NCDs), such as hypertension, cardiac diseas...e, chronic lung disease and cancer.
more
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv...e equipment (PPE) for specimen collection;
addressing chemical hazards and their safe disposal; and
the fourth edition of the WHO Laboratory Biosafety Manual (LBM4) is now available and the terminology in this guidance was aligned with the LBM4.
more